Urinary liver-type fatty acid-binding protein in septic shock: Effect of polymyxin B-immobilized fiber hemoperfusion

Shock

Volumn 31, Issue 5, 2009, Pages 454-459

  Nakamura, Tsukasa ^a   Sugaya, Takeshi ^b   Koide, Hikaru ^c  

^a Shinmatsudo Central General Hospital   (Japan)

^b RIKEN KOBE INSTITUTE   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

Fatty acid binding protein; Polymyxin B immobilized fiber; Renal proximal tubule; Septic shock

Indexed keywords

CREATININE; ENDOTOXIN; FATTY ACID BINDING PROTEIN; POLYMYXIN B;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INDEX; HEART OUTPUT; HEMOPERFUSION; HUMAN; MALE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEPTIC SHOCK; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; HEMODYNAMICS; METHODOLOGY; MIDDLE AGED; SEPSIS; URINE;

AGED; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; HEMODYNAMICS; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; POLYMYXIN B; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC;

EID: 67649379260     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181891131     Document Type: Article

References (42)

1. Lawrie LC, Dundas SR, Curran S, Murray GI: Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer 90:1955-1960, 2004.
2. Hamilton JA, Era S, Bhamidipati SP, Reed RG: Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci U S A 88:2051-2054, 1991.
3. Maatman RG, van de Westerlo EM, van Kuppevelt TH, Veerkamp JH: Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 288:285-290, 1992.
4. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, Hirata Y, Goto A, Omata M: Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 143:23-30, 2004.
5. Tepel M, Zindek W: N-acetylcysteine in nephrology; contrast nephropathy and beyond. Curr Opin Nephrol Hypertens 13:649-654, 2004.
6. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H: Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 47:439-444, 2006.
7. Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, et al.: Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 39:937-947, 2002.
8. De Vriese AS: Prevention and treatment of acute renal failure in sepsis. J Am Soc Nephrol 14:792-805, 2003.
9. Khan RZ, Badr KF: Endotoxin and renal function: prospectives to the understanding of septic acute renal failure and toxic shock. Nephrol Dial Transplant 14:814-818, 1999.
10. Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux PR: Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292:F261-F268, 2007.
11. Bisulfate B, David S, Cambia V, Tobias PS, Camass G: Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. Int J Mol Med 10:441-449, 2002.
12. Shoji H: Extracorporeal endotoxin removal for the treatment of sepsis. Endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 7:108-114, 2003.
13. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H: Modulation of human leukocyte antigen-DR on monocytes and CD 16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 188:150-156, 2004.
14. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: Prognosis in acute organ-system failure. Ann Surg 202:685-693, 1985.
16. Aoki H, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 167:412-417, 1994.
17. Nagai K, Thogersen HC: Generation of beta-globin by sequence-specific proteolysis of a hybrid protein produced in Escherichia coli. Nature 309: 810-812, 1984.
18. Kearney JF, Radbruch A, Liesegang B, Rajewsky K: A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 123:1548-1550, 1979.
19. Hayashida N, Chihara S, Akasu K, Oda T, Tayama E, Kai E, Kawara T, Aoyagi S: Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery. Jpn Circ J 64:18-22, 2000.
20. Meunier-Durmort C, Poirier H, Niot I, Forest C, Besnard P: Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids. Biochem J 319:483-487, 1996.
21. Huang H, Starodub O, McIntosh A, Kier AB, Schroeder F: Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem 277: 29139-29151, 2002.
22. Wolfrum C, Borrmann CM, Borchers T, Spener F: Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci USA 98: 2323-2328, 2001.
23. Issermann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650, 1990.
24. Price RG: Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine. Methods and clinical applications. Eur J Clin Chem Clin Biochem 30:693-705, 1992.
25. Thijs A, Thijs LG: Pathogenesis of renal failure in sepsis. Kidney Int 53(suppl 66):S34-S37, 1998.
26. Sugaya T, Yamamoto T, Noiri E, Ono Y, Hattori R, Kinugawa T, Ohshima S: Urinary fatty acid binding protein (FABP) as the sensitive marker of renal ischemia: direct evidences by intravital video CCD analysis on the post-transplant human kidney. J Am Soc Nephrol 14:568A, 2003.
27. Wangle F, Patel M, Razavi HM: Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med 165:1634-1639, 2002.
28. Yasuda H, Yuen PST, Hu X, Zhou H, Star RA: Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 69:1535-1542, 2006.
29. Pelsers MM, Hermens WT, Glatz JF: Fatty acid-binding protein as plasma markers of tissue injury. Clin Chim Acta 352:15-35, 2005.
30. Kamijo A, Sugaya T, Hikawa A: Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 165: 1243-1255, 2004.
31. Kamijo A, Sugaya T, Hikawa A: Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 284: 175-182, 2006.
32. Schefold JC, von Haehling S, Corsepius M, Pohle C, Kruschke P, Zuckermann H, Volk HD, Reinkl P: A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin-6, and complement-activating product 5a. Shock 28:418-425, 2007.
33. Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, Uchiyama Y, Akizawa T, Takahashi K, Sugai K: Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B-immobilized column. Artif Organs 22:1038-1044, 1998.
34. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, Kanno Y, Suzuki H: Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 19:361-369, 2001.
35. Sager RA, Johnson AC, Hanson SY, Lund S: Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release. Am J Physiol Renal Physiol 289:F289-F297, 2005.
36. Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, et al.: Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 18:2894-2902, 2007.
37. Nakamura T, Kawagoe Y, Ueda Y, Node K, Koide H: Polymyxin B-immobilized fiber hemoperfusion reduces urinary 8-hydroxy-2′-deoxyguanosine levels in patients with septic shock. Clin Intensive Care 17:95-100, 2008.
38. Mishra V, Baines M, Wenstone R, Shenkin A: Markers of oxidative damage, antioxidant status, a clinical outcome in critically ill patients. Ann Clin Biochem 42:269-276, 2005.
39. Li L, Shoji W, Takano H, Nishimura N, Aoki Y, Takahashi R, Goto S, Kaifu T, Takai T, Obinata M: Increased susceptibility of MER5 knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun 35:715-721, 2007.
40. Lerolle N, Guiro E, Fairy C, Bernstein C, Diehl JL, Fagan JY: Renal failure in septic shock. Predictive value of Doppler-based renal arterial resistive index. Int Care Med 32:1553-1559, 2006.
41. Sato T, Shoji H, Koga N: Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience. Ther Apher Dial 7:252-258, 2003.
42. Hirasawa H, Oda S, Matsuda K: Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol 156:365-370, 2007.